Contracts

Tyrosine-Kinase Inhibitor

Applicable to all London trusts providing cancer services.

NHS LPP is currently monitoring the uptake of generic TKIs and the cost savings achieved within London due to this change. The volumes are taken from IQVIA and Define databases. The contract is owned by the Commercial Medicines Unit.

Request a customer access agreement

*
*
*
*
*